Yes but didn’t they say TNBC was a long shot for
Post# of 155611
(Total Views: 489)
Posted On: 03/31/2022 12:15:35 PM
Yes but didn’t they say TNBC was a long shot for BTD. Basically we don’t have enough data for cancer. That’s how I heard it.
Doesn’t change that we need more trials, but why would Scott say some TNBC patients stoped getting Leronlimab after the trial was done once they went back and checked the information? Or he said something the the effect that not everyone was getting Leronlimab once it was done.
I’m confused as to why that would even happen to begin with.
Doesn’t change that we need more trials, but why would Scott say some TNBC patients stoped getting Leronlimab after the trial was done once they went back and checked the information? Or he said something the the effect that not everyone was getting Leronlimab once it was done.
I’m confused as to why that would even happen to begin with.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com